Navigation Links
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
Date:2/11/2009

CHENGDU, China, Feb. 11 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that management will hold a conference call to discuss its 2009 fiscal second quarter at 8:45 a.m. EST on Wednesday, February 18, 2009. Financial results will be released on February 17, 2009 after the market closes.

Interested parties may access the call by dialing +1-800-762-8795 from within the United States, or +1-480-629-9031 if calling internationally. The conference ID is 3987044. It is advisable to dial in approximately 5-10 minutes prior to the start of the call. A replay will be available through March 4, 2009 and can be accessed by dialing +1-800-406-7325 (U.S.), +1-303-590-3030 (Int'l), passcode 3987044.

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at http://www.viavid.net or at the following link: http://viavid.net/dce.aspx?sid=00005DDB . To access the web cast, you will need to have the Windows Media Player on your desktop. For the free download of the Media Player please visit: http://www.microsoft.com/windows/windowsmedia/en/download/default.asp .

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 33 modernized TCMs and 5 generic western medicines in the market, 22 of which are listed in
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
2. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
3. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
4. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
5. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
6. Tianyin Pharmaceutical Appoints Three New Independent Board Members
7. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
8. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
9. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
10. Mach One Executes Definitive Agreement to Acquire Biopharmaceutical Design & Engineering Firm
11. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...OOMINGTON, Minn., Nov. 30 Acuo Tec...image management software, data migration tools an...a Hospitals and Clinics for a new Vendor Neutral A...orage across the Allina network of hospitals, clin...s based on the Acuo Technologies DICOM Services Gr...
(Date:11/30/2009)...OCKVILLE, Md., Nov. 30 N...cine company, announced today that the company wil...ference 2009 on December 2, 2009 at 12:30 pm local...ill provide an overview of the company,s business ...coming milestones. A link to the live audio only ...
(Date:11/30/2009)... AMSTERDAM, November 30 Biopharm...at the first patients have been enrolled in its,mu...TM). The study is,designed to show reduction in tr...llowing an allogeneic stem cell transplantation wi...ancer patients eligible for an allogeneic,stem cel...
(Date:11/30/2009)... CHANGCHUN, China and LOS ANGELES, Nov. 30 /PR...uticals, Inc. (OTC Bulletin Board: CYXN; ,China Yo...g manufacturer, distributor and,retailer of pharma...t has,completed preparation for distribution of me... Chinese government recently formalized the nation...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3
...HILADELPHIA, Pennsylvania and DUBLIN, Ireland, Feb...he global,specialty biopharmaceutical company anno...a year which has seen significant growth in Shire,...s, Full Year 200... $2.75bn + 27% $0.70 bn + 7%...
...ogen board; , , - finally accepts legitima...ing; , , - will not allow shareholder vote... with high risk, high funding, Avexa merger propos...th refusal to align meeting dates , , Shareholder...RNE, Australia, Feb. 19 A general meeting of Prog...
...res Quarterly Dividend , , ACTON, Mass., Feb. 18 ...nnounced fourth quarter and year-end financial res...Company also announced a quarterly dividend of $0....of March 6, 2009 to be paid on March 20, 2009. Th...y dividend. , , The Company,s revenue for the yea...
Other Biology Technology:Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 2Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 3Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 4Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 5Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 6Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 7Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 8Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 9Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 10Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 11Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 12Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 13Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 14Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 15Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 16Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 17Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 18Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 19Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 20Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 21Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 22Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 23Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 24Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 25Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 26Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 27Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 28Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 29Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 30Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 31Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 32Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 33Progen Concedes Shareholder Requisitioned Meeting 2Progen Concedes Shareholder Requisitioned Meeting 3Progen Concedes Shareholder Requisitioned Meeting 4
(Date:11/30/2009)... German . , The DFG has approved the establi... of 1 January 2010. This decision was made recentl...w centres will initially be funded for four years ...nt overhead funding for indirect costs will also b... topics range from modern prostheses to political ...
(Date:11/30/2009)... Global Conference on Systems & Enterprises (GCSE)..., focuses on the convergence of complex large-scal...o society. , The goal of the conference is t...rgeted complex systems, examined by domain, each s...al Infrastructure Systems, including Intelligent/S...
(Date:11/30/2009)...ch is the virus,s exquisite specialisation for its...tools, like the humble lab mouse, can deliver only...riting in BioMed Central,s open access Journal of...roblem by creating a mouse that has key features o..., George Kassiotis, from the Division of Immunore...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2A reductionist approach to HIV research 2Initial Slate of Speakers and Sponsors Announced for BioConference Live Online Conference for the Life Science Community on November 17 19 56763 1Initial Slate of Speakers and Sponsors Announced for BioConference Live Online Conference for the Life Science Community on November 17 19 56763 2Initial Slate of Speakers and Sponsors Announced for BioConference Live Online Conference for the Life Science Community on November 17 19 56763 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 1New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 2New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 4New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 5Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 1Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 3Access Pharmaceuticals Provides Update on ProLindac 28TM 29Clinical Development Plan 13977 4
...orhiza punctata, first reported in great quantitie...us reappearance this summer in waters from southwe... Beachgoers and boaters are encouraged to report t...hin Island Sea Labs jellyfish website, Dockwatch, ...llorhiza sightings have occurred in the Gulf as fa...
...tinely added to consumer products from carpets to ...ealth officials, however, are concerned that one c...enylethers (PBDEs), may be doing more than reducin...fter several decades of use, PBDEs are widely dist...ace levels of these chemicals can be measured in a...
...echnology (NIST) has issued a suite of Standard Re... the most popular dietary supplements in the marke...1 billion. , The NIST reference materials are de...f analytical methods for flavonoids and terpene la...with the perceived effectiveness of ginkgo) as wel...
Other Biology News:Invasive Australian jellyfish sighted in Gulf of Mexico in summer 2007 2SRMs track fire retardants in humans and environment 2Ginkgo SRMs: Tools for product analysis/quality 2
Taq DNA Polymerase (Thermus aquaticus) from GE Healthcare, formerly Amersham Biosciences
AmpliTaq DNA Polymerase with Buffer II from Applied Biosystems
AmpliTaq DNA Polymerase with Buffer I from Applied Biosystems
Mango-Taq DNA Polymerase from Bioline
Biology Products: